13D Filing: James Flynn’s Deerfield Management Takes 9.99% Stake in Newly-Public AveXis, Inc. (AVXS)

Page 14 of 17

Page 14 of 17 SEC Filing

CUSIP No.
05366U100
Page 16 of 20 Pages
Item 7.
Material to be Filed as Exhibits.
Exhibit 99.1
Joint Filing Agreement dated as of February 19, 2016 by and among the Reporting Persons.*
Exhibit 99.2
Power of Attorney (incorporated by reference to Exhibit 24 to the Form 3 with regard to Editas Medicine, Inc. filed with the Securities and Exchange Commission on February 2, 2016 by Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield PDI Financing, L.P., Deerfield PDI Financing II, L.P., Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P., Deerfield International Master Fund, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt HIF, L.P., Breaking Stick Holdings, LLC, Deerfield Private Design Fund III, L.P. and James E. Flynn.
 
* Filed herewith.

Follow Avexis Inc.

Page 14 of 17